As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.
8 Analysts have issued a Greenwich LifeSciences Inc forecast:
8 Analysts have issued a Greenwich LifeSciences Inc forecast:
| Sep '25 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | - - |
-
|
|
| EBITDA | -20 -20 |
82%
82%
|
|
| EBIT (Operating Income) EBIT | -20 -20 |
82%
82%
|
|
| Net Profit | -19 -19 |
86%
86%
|
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.
| Head office | United States |
| CEO | Snehal Patel |
| Employees | 6 |
| Founded | 2006 |
| Website | greenwichlifesciences.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


